Connect with us

Top Stories

Some Americans could need COVID-19 vaccine booster -Fauci

Some Americans could need COVID-19 vaccine booster -Fauci 1

By Linda So

WASHINGTON (Reuters) -Top infectious disease official Anthony Fauci said on Sunday that Americans who are immune compromised may end up needing COVID-19 vaccine booster shots as the United States deals with increasing cases from the Delta variant of the coronavirus.

“Those who are transplant patients, cancer chemotherapy, auto-immune diseases, that are on immunosuppressant regimens, those are the kind of individuals that if there’s going to be a third booster, which might likely happen, would be among first the vulnerable,” Fauci said during a CNN interview.

He added health officials are also considering whether to revise mask guidance for vaccinated Americans saying it was “under active consideration.”

Citing studies that show there might be waning immunity in vaccinated people, Fauci said U.S. health officials are reviewing data to determine when boosters might be needed.

“It’s a dynamic situation. It’s a work in progress, it evolves like in so many other areas of the pandemic,” said Fauci, the director of the National Institute of Allergy and Infectious Diseases. “You’ve got to look at the data.”

Last week, Israel’s health ministry reported a decrease in the effectiveness of the Pfizer vaccine in preventing infections and symptomatic illness. But it added that the two-dose COVID-19 vaccine developed by Pfizer with partner BioNTech still remained highly effective in preventing severe illness.

The decline in efficacy coincided with the spread of the Delta variant, now the dominant strain in Israel.

Israel is administering third doses of the vaccine to immunocompromised people, including those who have had heart, lung, kidney or liver transplants and cancer patients receiving chemotherapy.

The Delta variant, which was first found in India, is driving up infections in the United States.

The sharpest increases in COVID-19 cases are in places with lower vaccination rates. Florida, Texas and Missouri account for 40% of all new cases nationwide, with around one in five of all new U.S. cases occurring in Florida, White House adviser Jeffrey Zients said last week.

The U.S. Centers for Disease Control and Prevention (CDC) on Sunday reported an uptick in the number of vaccine doses administered in the past 24 hours — 778,996, the highest number given in a 24-hour period since the United States reported giving 1.16 million doses on July 3.

However, that number is far below the peak of 4.63 million doses reported on April 10 and, despite the rise, the pace of vaccinations is still generally declining, CDC data shows.

Since vaccines became widely available in the spring, President Joe Biden’s White House has been conducting an aggressive campaign to get shots in arms that has been met with skepticism in some states and communities.

White House Chief of Staff Ronald Klain on Sunday hailed the CDC numbers as a sign vaccinations were picking back up.

Pfizer and BioNTech said on Friday that the United States had purchased 200 million more doses of their vaccine to help with pediatric vaccination as well as possible booster shots.

(Reporting by Linda So; Additional reporting by Maria Caspani in New York; Editing by Tim Ahmann, Grant McCool and Sonya Hepinstall)

Editorial & Advertiser disclosure
Our website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
Global Banking and Finance Review Awards Nominations 2021
2021 Awards now open. Click Here to Nominate

Recommended

Newsletters with Secrets & Analysis. Subscribe Now